IDT CORP IDT Cash Flow

Idt corp (IDT)

CashFlow / Quarterly

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14	Apr'14	Jan'14	Oct'13	Jul'13	Apr'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Apr'11	Jan'11	Oct'10
Operating activities
Net income (loss)
904	-1,422	-3,168	6,507	-1,011	-1,998	8,535	-3,230	1,691	-1,797	-9,458	-4,453	1,258	22,294	11,417	4,701	4,665	4,575	1,881	1,123	2,757	80,354	8,388	5,599	2,973	4,050	-3,343	9,124	3,495	4,168	37,480	3,449	2,929	-5,073	-1,480	5,822	3,190	15,839
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Net loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1,812	-957	-413	-1,452	4,836	0	0	3,015	187	664	-1,133	2,666
Depreciation and amortization
5,184	5,295	5,751	5,524	5,763	5,594	5,594	5,799	5,735	5,673	5,629	5,474	5,302	5,299	4,992	5,518	4,973	5,052	4,956	4,617	4,440	4,405	4,210	4,153	4,059	3,896	3,938	3,972	3,865	3,135	3,812	4,163	4,231	4,442	-	-	-	-
Deferred income taxes
1,108	479	-1,764	14	918	1,117	1,650	1,312	1,895	1,317	12,650	-2,111	1,615	-14,483	-2,104	1,205	1,923	2,785	3,701	-265	1,847	594	-4,122	3,995	1,314	1,300	3,410	6,107	2,743	2,938	-36,928	0	0	-997	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,504	5,679
Severance and other payments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	815	315	257
Deferred income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-36	240	0
Provision for doubtful accounts receivable
917	549	810	598	173	447	1,079	424	130	566	253	307	-134	260	919	114	-387	873	7	55	-9	44	-867	819	185	363	226	731	287	1,499	776	368	-154	1,108	280	1,053	692	1,294
Realized loss (gain) on securities
-	-	-	-	-	-	-	-	-	7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of interest in Fabrix Systems Ltd.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	1,235	484	75,145	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Realized loss (gain) on marketable securities
-	-	-	-	-	-	-	-	-	-	-	26	305	0	0	0	0	543	-54	54	-94	40	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	5,379
Gain on proceeds from insurance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	571	0	0	0	0	-	-	-	-	-	-	-	-
Gain on proceeds from insurance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	774	1,863
Interest in the equity of investments
-	-	-	-	-	-	-	-	-	-104	-	107	32	263	17	-458	234	-155	44	196	-439	1,898	-151	581	117	735	427	941	308	292	128	1,827	-542	-256	238	367	-1,000	338
(i) Stock-based compensation included in selling, general and administrative expenses
1,167	1,364	1,024	332	467	413	739	1,045	987	810	947	665	1,426	702	363	673	873	771	1,173	992	2,172	848	462	793	1,632	2,495	1,535	1,522	1,806	1,012	702	1,007	932	684	764	1,641	1,332	344
Other
378	34	1,065	622	124	-46	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in assets and liabilities:
Restricted cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	566	5,841	-9,939	7,891	9,297	13,755	-8,395	16,886	3,488	11,681	-3,769	11,014	-4,799	20,216	-1,139	6,283	4,062	7,223	5,438	-	-	-	-	-	-	-	-
Trade accounts receivable
1,722	-7,975	6,451	3,288	-17,236	-97	9,611	-7,511	-9,384	13,952	-911	10,694	-4,943	13,132	1,142	-3,124	-725	2,091	7,904	-5,259	4,079	-7,364	2,655	2,173	58	-3,523	-699	-3,596	2,105	-15,416	6,877	-22,423	5,765	1,053	-5,378	3,803	3,343	23,206
Prepaid expenses, other current assets and other assets
149	9,166	-3,906	-134	-8,845	8,766	5,453	-1,673	2,277	12,832	-1,209	4,633	1,422	10	-1,922	1,194	-5,292	-2,352	482	3,183	-2,850	-2,937	2,970	-461	-577	2,696	2,524	-1,630	-3,401	-383	5,010	2,983	1,383	-7,276	-1,859	4,528	1,779	-2,667
Trade accounts payable, accrued expenses, other current liabilities and other liabilities
-1,476	-10,012	10,886	-3,244	-22,107	6,919	33,844	-728	-10,988	-9,359	8,234	23,498	-21,135	6,125	4,808	-4,093	-7,349	-3,465	1,162	2,191	2,288	-9,766	8,524	8,862	-14,965	-8,335	3,569	-9,790	-9,712	-6,645	7,506	2,679	13,082	-12,564	9,873	7,811	21,854	-337
Customer deposits at IDT Financial Services Limited (Gibraltar-based bank)
-22,406	1,793	25,991	4,071	23,448	5,567	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Customer deposits
-	-	-	-	-	-	-	-	-	-14,226	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-1,462	-1,798	1,863	-719	-3,791	-1,206	-13,301	-3,428	-3,154	-1,556	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Customer deposits
-	-	-	-	-	-	-	-	-	-	-	-1,226	7,950	-9,127	8,316	8,828	13,185	-4,985	14,770	2,976	12,132	-3,939	14,083	-6,674	16,026	6,751	5,021	2,673	6,792	3,512	5,417	441	1,911	1,288	-	-	-	-
Income taxes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	148	-	14	-1	-291	13	-707	522	143	-896	892	292	-864	-533	-2,028	-726	-1,434	-907	434	416	-1,373
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-4,800	71	-2,114	-886	1,895	1,271	-69	85	-1,977	-22	-1,025	1,882	1,162	1,563	4,310	1,591	2,042	2,446	174	4,577	2,064	4,302	-4,277	-2,890	239	-2,491	13,184
Net cash (used in) provided by operating activities
-18,313	-4,977	37,783	9,307	29,817	8,230	19,270	24,438	21,945	-45,259	35,580	1,328	-6,304	5,490	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investing activities
Net cash provided by operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,687	11,193	13,953	-	6,829	12,663	8,291	16,085	20,508	-6,505	15,633	12,101	18,453	6,192	20,450	3,555	24,426	19,901	-13,359	8,176	12,026	26,659	3,588
Capital expenditures
3,805	3,851	4,957	4,328	4,933	4,463	4,598	5,038	5,607	5,324	5,899	6,507	5,028	5,515	4,406	4,741	3,704	5,519	5,746	8,864	7,835	6,111	4,590	4,584	4,206	3,641	3,609	3,466	3,912	3,550	3,402	2,989	2,513	1,926	4,161	3,108	2,733	3,298
Proceeds from redemption of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	6	609	17	48	28	20	23	0	19	43	976	7	8	97	2	4	148	2,674	343	758	42	1,112	534
Proceeds from sale of interest in Straight Path IP Group Holding, Inc.
-	-	-	-	-	-	-	-	-	6,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of IP Interest from Straight Path Communications Inc.
-	-	-	-	-	-	-	-	-	-6,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collection of notes receivable, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-750	-	-	-	-	-	-	-	-
Collection of notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Cash used for purchase of investments
-	-	-	-	-	-	-	-	-	-	-	223	296	8,008	152	1,500	350	0	0	0	-93	218	-250	425	0	0	-	-	1,000	69	0	0	0	0	2,965	0	0	50
Proceeds from sale of interest in Straight Path IP Group Holding, Inc.
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of IP interest from Straight Path Communications Inc.
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of interest in Fabrix Systems Ltd.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,788	0	0	4,769	23,223	416	0	36,039	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for acquisitions, net of cash acquired
-	-	0	73	0	5,453	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash used for purchase of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-240	283	813	4,407
Proceeds from redemptions of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-240	0	0	3,540	91	523	1,644	0
Proceeds from sale of building
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	100
Proceeds from insurance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	571	-	0	0	0	-	-	-	-	0	0	837	2,687
Increase in restricted cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,876	1,538	1,056	-	392	-3,833	-1,074
Purchases of debt securities and equity investments
799	8,195	-	-	-	-	315	2,411	4,126	15,671	14,682	21,511	6,240	10,969	17,109	5,320	9,569	14,911	16,858	17,120	9,317	9,065	4,968	4,059	4,237	7,394	6,961	4,453	0	0	-	-	-	-	-	-	-	-
Proceeds from maturities and sales of debt securities and redemptions of equity investments
1,890	782	0	-243	2,183	3,372	4,847	5,045	12,050	19,560	17,160	13,988	10,847	6,001	10,835	5,456	9,859	8,861	7,286	4,736	5,286	6,818	4,366	2,863	4,026	6,068	1,412	300	0	0	-	-	-	-	0	0	0	5,731
Net cash used in investing activities
-3,164	-11,264	-12,226	-4,151	-3,250	-6,544	-119	-2,404	2,317	-1,435	-4,317	-14,253	-2,546	-18,489	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing activities
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,099	-3,155	-6,783	-	-20,804	-11,753	27,486	-4,942	-6,186	-4,374	-3,420	-9,244	-8,711	-4,815	-2,867	-9,720	5,835	-1,377	901	-10,640	-3,218	3,880	2,371
Dividends paid
-	-	-	-	-	-	2,264	2,237	4,720	4,720	4,719	4,390	4,386	4,379	4,375	4,357	4,427	4,199	4,423	4,280	34,941	3,950	3,948	3,933	3,917	1,837	-1	0	13,699	3,425	3,415	3,414	2,968	5,217	5,217	0	9,961	0
Distributions to noncontrolling interests
230	240	333	450	398	339	17	306	337	380	343	322	428	389	289	325	620	600	600	700	0	750	601	661	125	501	700	729	416	400	400	530	300	350	385	525	550	550
Repayment of other liabilities.
60	19	19	20	16	599	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	689	1,092	1,092	1,182	1,109	1,438
Proceeds from borrowings under revolving credit facility
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,000	13,000	15,000	15,000	21,062	0	0	0	-	-	-	-	-	-	-	-
Proceeds from sale of member interests in CS Pharma Holdings, LLC
-	-	-	-	-	-	-	-	-	-	0	0	0	1,250	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash of Rafael deconsolidated as a result of spin-off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	11,892	92,351	-	0	0	0
Proceeds from sale of member interests in CS Pharma Holdings, LLC.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of stock of subsidiary
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,133	0	0	1,804	0	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
0	276	-	-	-	-	-	-	-	-	1	0	428	407	0	0	0	0	-	-	-	-	0	81	5	523	921	0	0	0	-	-	-	-	-	-	-	-
Repayment of note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	6,353	70	69	67	13,065	13,066	15,065	15,063	21,124	21,124	62	60	58	59	58	55	160	4,133	160	157	152
Repurchases of Class B common stock
-	-	0	12	16	3,854	2,232	0	38	23	0	0	1,815	23	0	0	4,750	23	2,499	0	144	559	50	0	851	104	1	0	252	826	2,606	0	210	0	-	-	-	-
Net cash (used in) provided by financing activities
-556	17	-352	-482	12,842	-4,792	-4,513	-11,830	-5,095	-5,123	9,869	6,288	-6,201	-3,134	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash, cash equivalents, and restricted cash and cash equivalents
2,726	11,426	-10,180	-1,764	4,354	-4,590	-6,429	-4,018	8,915	575	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents
-19,307	-4,798	15,025	2,910	43,763	-7,696	8,209	6,186	28,082	-51,242	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,682	-9,797	-11,175	-	-4,628	-32,256	-18,324	-4,665	-6,578	-4,951	-9,176	-14,832	-791	-16,086	-4,709	-6,480	-4,002	-15,981	-99,170	-18,511	-655	-11,335	-2,140
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1,368	-156	-876	-238	-1,095	0	0	-889	-1,788	8,948	-2,801	2,030
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,040	0	0	-2,048	-379	-1,148	-980	-1,519
Net cash used in discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,945	0	0	-2,937	-3,695	7,800	6,219	511
Effect of exchange rate changes on cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	565	647	-1,476	-2,453	1,715	-4,199	-884	-112	216	-3,715	-3,074	318	1,122	-1,471	825	-182	-656	78	2,001	-267	-181	-1,265	-622	-284	1,246	-255	805
Net decrease in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-6,072	-14,404	-17,609	8,402	1,621	-5,958	-4,889	-4,393	-18,387	-35,061	14,379	6,796	8,866	-17,301	3,862	-13,875	8,139	-15,507	14,637	-6,967	26,078	1,278	-115,187	-24,954	17,199	25,168	5,135
Supplemental schedule of non-cash investing and financing activities
Net assets excluding cash and cash equivalents of Rafael deconsolidated as a result of spin-off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-11,892	30,695	-	0	0	0
Reclassification of liability for member interests in CS Pharma Holdings, LLC
-	-	-	-	-	-	-	-	-	-	0	0	0	8,750	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net liabilities excluding cash and cash equivalents of Fabrix Systems Ltd. sold
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	14,333	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Adjustment to liabilities in connection with the Straight Path Communications, Inc. spin-off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,624	0	0	0	0	-	-	-	-	-	-	-	-
Contribution due to Genie in connection with the spin-off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,892	-	-	-	0
Net assets excluding cash and cash equivalents of subsidiaries deconsolidated as a result of the Genie spin-off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-11,892	30,695	-	0	0	0